nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of Docetaxel to Androgen Receptor Axis–targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis
|
Roy, Soumyajit |
|
|
5 |
5 |
p. 494-502 |
artikel |
2 |
A Swinging Pendulum: Bringing Back Cytoreductive Nephrectomy in the Era of Immune Checkpoint Inhibition
|
Pallauf, Maximilian |
|
|
5 |
5 |
p. 585-586 |
artikel |
3 |
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial
|
Dai, Bo |
|
|
5 |
5 |
p. 519-525 |
artikel |
4 |
Contents
|
|
|
|
5 |
5 |
p. iii-v |
artikel |
5 |
Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
|
Chu, Carissa E. |
|
|
5 |
5 |
p. 537-543 |
artikel |
6 |
Double or Triple Trouble in Metastatic Hormone-sensitive Prostate Cancer?
|
Kostos, Louise |
|
|
5 |
5 |
p. 503-504 |
artikel |
7 |
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
|
Fanti, Stefano |
|
|
5 |
5 |
p. 530-536 |
artikel |
8 |
Editorial Board
|
|
|
|
5 |
5 |
p. i-ii |
artikel |
9 |
Erratum to “Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)” [Eur Urol Oncol 2021;4:543–52]
|
Morris, Michael J. |
|
|
5 |
5 |
p. 603 |
artikel |
10 |
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial
|
Witjes, Johannes Alfred |
|
|
5 |
5 |
p. 553-563 |
artikel |
11 |
Intermediate-risk Non–muscle-invasive Bladder Cancer: Time To Tidy Up the Mess?
|
Soria, Francesco |
|
|
5 |
5 |
p. 517-518 |
artikel |
12 |
Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
|
Tan, Wei Shen |
|
|
5 |
5 |
p. 505-516 |
artikel |
13 |
Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future Developments
|
Fossati, Nicola |
|
|
5 |
5 |
p. 587-600 |
artikel |
14 |
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
|
Pignot, Géraldine |
|
|
5 |
5 |
p. 577-584 |
artikel |
15 |
Prostatectomy in Patients with Oligometastatic Hormone-sensitive Prostate Cancer? Not Yet
|
Blanchard, Pierre |
|
|
5 |
5 |
p. 526-527 |
artikel |
16 |
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study
|
Lenis, Andrew T. |
|
|
5 |
5 |
p. 544-552 |
artikel |
17 |
Quality of Life Data in CheckMate 274: Does It Move the Needle?
|
Bergerot, Cristiane Decat |
|
|
5 |
5 |
p. 564-565 |
artikel |
18 |
Radical Prostatectomy or Radiotherapy in Oligometastatic Prostate Cancer: Is It Nearly Time To Call It a Draw?
|
Graefen, Markus |
|
|
5 |
5 |
p. 528-529 |
artikel |
19 |
Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion – Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis
|
Kotamarti, Srinath |
|
|
5 |
5 |
p. 483-493 |
artikel |
20 |
Re: Stefano Fanti, Alberto Briganti, Louise Emmett, et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022;5:530–6
|
Lopci, Egesta |
|
|
5 |
5 |
p. 601-602 |
artikel |
21 |
Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis
|
Huang, Junjie |
|
|
5 |
5 |
p. 566-576 |
artikel |